Next Article in Journal
Autophagy Modulates Immunogenic Cell Death in Cancer
Previous Article in Journal
Correction: Rizzo et al. Endoscopic Ultrasound-Guided Anastomoses of the Gastrointestinal Tract: A Multicentric Experience. Cancers 2025, 17, 910
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 18
Issue 2
10.3390/cancers18020204
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Cancers 2021, 13(4), 825.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Kingshott et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. Cancers 2021, 13, 825

by
Georgina Kingshott
1,*,†,
Kalina Biernacka
1,†,
Alex Sewell
2,
Paida Gwiti
2,3,
Rachel Barker
1,
Hanna Zielinska
1,
Amanda Gilkes
4,
Kathryn McCarthy
5,
Richard M. Martin
6,7,
J. Athene Lane
8,
Lucy McGeagh
9,
Anthony Koupparis
10,
Edward Rowe
10,
Jon Oxley
2,
Jeff M. P. Holly
1,‡ and
Claire M. Perks
1,‡
1
IGF & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, Learning & Research Building, Southmead Hospital, Bristol BS10 5NB, UK
2
Department of Cellular Pathology, North Bristol NHS Trust, Southmead Hospital, Bristol BS10 5NB, UK
3
Department of Pathology, North West Anglia NHS Foundation Trust, Peterborough PE3 9GZ, UK
4
Department of Haematology, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
5
Department of Surgery, Department of Medicine, Southmead Hospital, Bristol BS10 5NB, UK
6
Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK
7
National Institute for Health Research, Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Biomedical Research Unit Offices, University Hospitals Bristol Education Centre, Dental Hospital, Lower Maudlin Street, Bristol BS1 2LY, UK
8
Bristol Randomised Trials Collaboration, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK
9
Supportive Cancer Care Research Group, Faculty of Health and Life Sciences, Oxford Institute of Nursing, Midwifery and Allied Health Research, Oxford Brookes University, Jack Straws Lane, Marston, Oxford OX3 0FL, UK
10
Department of Urology, Bristol Urological Institute, Southmead Hospital, Bristol BS10 5NB, UK
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this paper as first authors.
‡
These authors contributed equally to this paper as senior authors.
Cancers 2026, 18(2), 204; https://doi.org/10.3390/cancers18020204
Submission received: 4 December 2025 / Accepted: 4 December 2025 / Published: 8 January 2026
Browse Figures
Versions Notes

Error in Figure

In the original publication [1], there was a mistake in Figure 2Aii, which had inadvertently been partially duplicated using part of panel 1C. We have assembled a new Figure 2Aii. In addition, there was an overlap in Figure 5B between panels A (benign) and D (cancer). We have assembled a new representative Figure 5B to replace this panel, and the figure legend has been corrected. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Supplementary Materials

The original uncropped Western Blot has been provided in the supplementary materials.

Reference

  1. Kingshott, G.; Biernacka, K.; Sewell, A.; Gwiti, P.; Barker, R.; Zielinska, H.; Gilkes, A.; McCarthy, K.; Martin, R.M.; Lane, J.A.; et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. Cancers 2021, 13, 825. [Google Scholar] [CrossRef] [PubMed]
Cancers 18 00204 g002
Figure 2. (Aii) glucose and dosed with 0, 1, 5 and 10 ng/mL TNFα showed two bands sized 229 and 292 bp, indicating a change from mono- to biallelic IGF-II expression and, therefore, loss of imprinting. (n = 3).
Figure 2. (Aii) glucose and dosed with 0, 1, 5 and 10 ng/mL TNFα showed two bands sized 229 and 292 bp, indicating a change from mono- to biallelic IGF-II expression and, therefore, loss of imprinting. (n = 3).
Cancers 18 00204 g002
Cancers 18 00204 g005
Figure 5. (B) Immunohistochemical analysis of IGF-II in two individuals, one with strong IGF-II staining in both benign (a) and cancer (b) tissue and one with weak IGF-II staining in both benign (c) and cancer (d) tissue. Scale bar = 300 um.
Figure 5. (B) Immunohistochemical analysis of IGF-II in two individuals, one with strong IGF-II staining in both benign (a) and cancer (b) tissue and one with weak IGF-II staining in both benign (c) and cancer (d) tissue. Scale bar = 300 um.
Cancers 18 00204 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kingshott, G.; Biernacka, K.; Sewell, A.; Gwiti, P.; Barker, R.; Zielinska, H.; Gilkes, A.; McCarthy, K.; Martin, R.M.; Lane, J.A.; et al. Correction: Kingshott et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. Cancers 2021, 13, 825. Cancers 2026, 18, 204. https://doi.org/10.3390/cancers18020204

AMA Style

Kingshott G, Biernacka K, Sewell A, Gwiti P, Barker R, Zielinska H, Gilkes A, McCarthy K, Martin RM, Lane JA, et al. Correction: Kingshott et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. Cancers 2021, 13, 825. Cancers. 2026; 18(2):204. https://doi.org/10.3390/cancers18020204

Chicago/Turabian Style

Kingshott, Georgina, Kalina Biernacka, Alex Sewell, Paida Gwiti, Rachel Barker, Hanna Zielinska, Amanda Gilkes, Kathryn McCarthy, Richard M. Martin, J. Athene Lane, and et al. 2026. "Correction: Kingshott et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. Cancers 2021, 13, 825" Cancers 18, no. 2: 204. https://doi.org/10.3390/cancers18020204

APA Style

Kingshott, G., Biernacka, K., Sewell, A., Gwiti, P., Barker, R., Zielinska, H., Gilkes, A., McCarthy, K., Martin, R. M., Lane, J. A., McGeagh, L., Koupparis, A., Rowe, E., Oxley, J., Holly, J. M. P., & Perks, C. M. (2026). Correction: Kingshott et al. Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. Cancers 2021, 13, 825. Cancers, 18(2), 204. https://doi.org/10.3390/cancers18020204

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop